Daniel H. Orenstein Net Worth

The estimated Net Worth of Daniel H. Orenstein is at least $2.45 Milion dollars as of 6 September 2022. Mr Orenstein owns over 2,838 units of Health Catalyst Inc stock worth over $791,884 and over the last 5 years he sold HCAT stock worth over $1,316,729. In addition, he makes $345,644 as Gen. Counsel & Sec. at Health Catalyst Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Orenstein HCAT stock SEC Form 4 insiders trading

Mr has made over 26 trades of the Health Catalyst Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 2,838 units of HCAT stock worth $31,984 on 6 September 2022.

The largest trade he's ever made was exercising 33,046 units of Health Catalyst Inc stock on 15 December 2020 worth over $341,696. On average, Mr trades about 4,147 units every 22 days since 2020. As of 6 September 2022 he still owns at least 99,608 units of Health Catalyst Inc stock.

You can see the complete history of Mr Orenstein stock trades at the bottom of the page.

Mr. Daniel H. Orenstein biography

Daniel H. Orenstein is the Gen. Counsel & Sec. at Health Catalyst Inc.

What is the salary of Mr Orenstein?

As the Gen. Counsel & Sec. of Health Catalyst Inc, the total compensation of Mr Orenstein at Health Catalyst Inc is $345,644. There are 6 executives at Health Catalyst Inc getting paid more, with Daniel Burton having the highest compensation of $3,519,720.

How old is Mr Orenstein?

Mr Orenstein is 51, he's been the Gen. Counsel & Sec. of Health Catalyst Inc since . There are 10 older and 9 younger executives at Health Catalyst Inc. The oldest executive at Health Catalyst Inc is John Kane, 67, who is the Independent Director.

What's Mr Orenstein's mailing address?

Daniel's mailing address filed with the SEC is C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN, UT, 84095.

Insiders trading at Health Catalyst Inc

Over the last 5 years, insiders at Health Catalyst Inc have traded over $32,461,176 worth of Health Catalyst Inc stock and bought 554,600 units worth $5,926,241 . The most active insiders traders include Daniel D. Burton, Mark B Templeton oraz Paul Horstmeier. On average, Health Catalyst Inc executives and independent directors trade stock every 8 days with the average trade being worth of $135,905. The most recent stock trade was executed by Benjamin Landry on 6 September 2024, trading 2,466 units of HCAT stock currently worth $18,224.

What does Health Catalyst Inc do?

health catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available. health catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. during development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data. after determining that the predominant approaches to data modeling weren’t effective for healthcare data, they discovered the solution, which is now known as the adaptive data architecture. using a late-binding bus architecture, catalyst’s adaptive data model is agile, flexible, and can be implemented in a matter of weeks compared to the months or years traditional app

Complete history of Mr Orenstein stock trades at Health Catalyst Inc

Health Catalyst Inc executives and stock owners

Health Catalyst Inc executives and other stock owners filed with the SEC include:

• Daniel Burton,
  Chief Executive Officer, Director
• Paul Horstmeier,
  Chief Operating Officer
• J. Patrick Nelli,
  Chief Financial Officer
• Daniel D. Burton,
  CEO & Director
• Paul Horstmeier,
  Chief Operating Officer
• J. Patrick Nelli Jr.,
  Pres
• Daniel H. Orenstein,
  Gen. Counsel & Sec.
• Linda Llewelyn,
  Chief People Officer
• John Kane,
  Independent Director
• Fraser Bullock,
  Independent Chairman of the Board
• Michael Dixon,
  Independent Director
• Duncan Gallagher,
  Independent Director
• Todd Cozzens,
  Independent Director
• Anita Pramoda,
  Independent Director
• Timothy Ferris,
  Director
• Adam Brown,
  Senior Vice President - Investor Relations
• S. Dawn Smith,
  Independent Director
• Julie Larson-Green,
  Independent Director
• Daniel Orenstein,
  General Counsel, Corporate Secretary
• Amanda Hundt,
  Vice President - Corporate Communications
• Linda Llewelyn,
  Chief People Officer
• Kyle J. Salyers,
  Sr. VP of Corp. Devel.
• Jason Jones,
  Chief Analytics & Data Science Officer and GM of Data & Analytics Platform
• Dave Ross,
  Chief Technology Officer
• Trudy Sullivan,
  Chief Communications and Diversity, Equity & Inclusion Officer
• Bryan Richard Hinton,
  Chief Technology Officer
• Jason Alger,
  Chief Accounting Officer
• Bryan Truman Hunt,
  Chief Financial Officer
• Dale Sanders,
  Chief Technology Officer
• Venture Partners Xi, Lp Nor...,
  
• Us (Ttgp), Ltd.Scgf V Manag...,
  
• Promod Haque,
  10% owner
• Mark B Templeton,
  
• Bryan Truman Hunt,
  Chief Financial Officer
• Bryan Richard Hinton,
  Chief Technology Officer
• Kevin Lee Freeman,
  Chief Commercial Officer
• Jason Alger,
  Chief Financial Officer
• Daniel Le Sueur,
  Chief Operating Officer
• Anne Marie Bickmore,
  COO and Chief Product Officer
• Benjamin Landry,
  General Counsel